Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Aiforia Technologies's annualizedNet Income for the quarter that ended in Dec. 2025 was €-12.10 Mil.
Aiforia Technologies's average Total Assets over the quarter that ended in Dec. 2025 was €29.92 Mil. Therefore, Aiforia Technologies's annualized ROA % for the quarter that ended in Dec. 2025 was -40.43%.
The historical rank and industry rank for Aiforia Technologies's ROA % or its related term are showing as below:
FRA:L6J'
s ROA % Range Over the Past 10 Years
Min: -62.19 Med: -41.11 Max: -30.24
Current: -43.08
During the past 8 years, Aiforia Technologies's highest ROA % was -30.24%. The lowest was -62.19%. And the median was -41.11%.
FRA:L6J's ROA % is ranked worse than 88.58% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.93
vs FRA:L6J: -43.08
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Aiforia Technologies's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aiforia Technologies ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aiforia Technologies's ROA % distribution charts can be found below:
* The bar in red indicates where Aiforia Technologies's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Aiforia Technologies (FRA:L6J) has a ROA % of -40.43% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Aiforia Technologies and its competitors. According to the industry distribution chart, Aiforia Technologies ranks #605 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 88.6%.
Is Aiforia Technologies' ROA % too high?
Aiforia Technologies' current ROA % is -40.43%. Based on the distribution chart, Aiforia Technologies ranks #605 out of 683 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Aiforia Technologies has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Aiforia Technologies' ROA % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Aiforia Technologies ranks #605 out of 683 companies for ROA %. This places Aiforia Technologies in the lower half of its industry. The industry median ROA % is 1.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.93, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Aiforia Technologies and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aiforia Technologies's current ROA % is -40.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aiforia Technologies stock overvalued right now?
Aiforia Technologies (FRA:L6J) has a current ROA % of -40.43%. The stock's GF Value™ is €3.51, compared to a current price of €1.00 — trading 71.5% below its estimated fair value. The current ROA % is -40.43%. Aiforia Technologies' overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Aiforia Technologies (FRA:L6J), the current ROA % is -40.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aiforia Technologies (FRA:L6J) Overvalued in 2026?
Based on GuruFocus' analysis, Aiforia Technologies stock appears to be undervalued.
The current stock price of €1.00 is trading 71.5% below its estimated GF Value™ of €3.51.
Key valuation signals for FRA:L6J:
ROA %: -40.43%
GF Value™: €3.51 vs. price of €1.00 (71.5% below fair value)
No single metric tells the full story. See the FRA:L6J stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aiforia Technologies PLC is a Finnish company developing artificial intelligence-based image analysis software for medical research and diagnostics and aiming for international growth. The company equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services plan to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more.
62GF Score
Get the complete analysis for FRA:L6J
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L6J has been successfully added to your 
